Overview

Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the difference between esomeprazole and placebo in the treatment of signs and symptoms as observed by 8-hour video and cardiorespiratory monitoring in neonatal patients.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Esomeprazole